Li, Chengtai. “Should CRISPR-Cas9 Be Used in Human Embryos to Eliminate Genetic Diseases? Public Attitudes and Benefit–Risk Analysis”. MedScien 4, no. 1 (February 28, 2026): 6812. Accessed October 23, 2026. https://ms.deanfrancis.press/article/view/28.